Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Lovitt

Trauma Surgery Dallas, TX Medical Doctor

NPI 1750310520 CMS profile 124968

2710 Swiss Avenue, Dallas, TX 75204

Open in the dashboard

General payments

$7,715

53 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Lovitt of Dallas, TX is reported in the CMS Open Payments database as having received $7,715 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Trauma Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,635 9
2024 General $75 1
2023 General $1,009 7
2022 General $171 1
2021 General $296 7
2020 General $150 6
2019 General $379 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Lovitt
  • Trauma Surgery median
  • Middle half of Trauma Surgery
  • National median

In program year 2025, general payments to Matthew Lovitt were reported at $5,635. Among 762 Trauma Surgery profiles paid that year, the median was $280 and the middle half received between $87 and $1,585.

Show as a table
Year Matthew Lovitt Trauma Surgery median Middle half National median
2019 $379 $153 $56–$644 $163
2020 $150 $123 $39–$342 $114
2021 $296 $142 $45–$556 $132
2022 $171 $172 $59–$732 $149
2023 $1,009 $213 $83–$1,200 $160
2024 $75 $237 $86–$1,280 $164
2025 $5,635 $280 $87–$1,585 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $6,541 14 payments
  2. TELA Bio, Inc. $336 5 payments
  3. Biom'Up France SAS $191 2 payments
  4. Merck Sharp & Dohme Corporation $113 8 payments
  5. Potrero Medical, Inc. $83 1 payment
  6. Boston Scientific Corporation $75 1 payment
  7. KCI USA, Inc $58 3 payments
  8. Mallinckrodt Enterprises LLC $49 3 payments
  9. E.R. Squibb & Sons, L.L.C. $35 3 payments
  10. TEI Biosciences Inc $28 1 payment
  11. Other $208 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $4,000 2 payments
  2. Travel and Lodging $2,064 6 payments
  3. Food and Beverage $1,635 44 payments
  4. Gift $16 1 payment
Products named General payments · program years 2019–2025
  1. DAVINCI XI $4,000 2 payments
  2. Da Vinci Surgical System $2,541 12 payments
  3. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $258 2 payments
  4. HEMOBLAST BELLOWS Hemostatic Agent $134 1 payment
  5. ZERBAXA $99 7 payments
  6. OviTex $77 3 payments
  7. SpyGlass Discover $75 1 payment
  8. HemoBlast Bellows Hemostatic Agent $56 1 payment
  9. OFIRMEV $49 3 payments
  10. VAC VERAFLO $37 2 payments
  11. Other $278 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$17,057

Medicare's payments for the services billed

Medicare patients

83

Average age 70

Services billed

137

36 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 60%
Diabetes 54%
Ischemic heart disease 53%
Heart failure 49%
Atrial fibrillation 48%
Arthritis 43%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Trauma Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record